-
April 1, 2019 Lupin appoints Ms. Christine Mundkur as an Independent Director
-
April 1, 2019 Lupin launches Tadalafil Tablets USP
-
March 28, 2019 Lupin launches Fluocinonide Ointment USP 0.05%
-
March 27, 2019 Lupin’s Pune Biotech facility receives EU GMP clearance
-
March 27, 2019 Lupin receives FDA approval for Tadalafil Tablets USP
-
March 26, 2019 Lupin and YL Biologics receives PMDA approval for Etanercept biosimilar in Japan
-
March 25, 2019 Lupin receives FDA approval for Sildenafil Tablets USP
-
March 22, 2019 Lupin launches generic Levothyroxine Sodium Tablets USP
-
March 7, 2019 Lupin receives FDA approval for Atorvastatin Calcium Tablets USP
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications